Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-13

Clinical Trial Update: Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans [Phase 1]

View source ↗

Summary

Phase I trial results evaluate the safety and preliminary efficacy of an injectable follistatin plasmid gene therapy in adults with frailty and aging. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Follistatin plasmid gene therapy (follistatin plasmid)

Snippet

Sponsor: Minicircle | Conditions: Frailty, Aging | Phase 1 | Status: COMPLETED